Acute treatment with relaxin protects the kidney against ischaemia/reperfusion injury

Although recent preclinical and clinical studies have demonstrated that recombinant human relaxin (rhRLX) may have important therapeutic potential in acute heart failure and chronic kidney diseases, the effects of acute rhRLX administration against renal ischaemia/reperfusion (I/R) injury have never...

Descripción completa

Detalles Bibliográficos
Autores principales: Collino, Massimo, Rogazzo, Mara, Pini, Alessandro, Benetti, Elisa, Rosa, Arianna Carolina, Chiazza, Fausto, Fantozzi, Roberto, Bani, Daniele, Masini, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117562/
https://www.ncbi.nlm.nih.gov/pubmed/24079335
http://dx.doi.org/10.1111/jcmm.12120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117562/
https://www.ncbi.nlm.nih.gov/pubmed/24079335
http://dx.doi.org/10.1111/jcmm.12120

Ejemplares similares